This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

PUVA and minimisation of skin cancer risk

Authoring team

NICE suggests guidance how to minimise skin cancer risk with PUVA:

  • do not use PUVA in people with psoriasis of any type and a genetic predisposition to skin cancer for example, xeroderma pigmentosum or familial melanoma

  • do not use PUVA when other appropriate treatments are available in:
    • people with a personal history of skin cancer or
    • people who have already received 150 PUVA treatments or
    • children

  • use PUVA with caution or consider other treatment options in:
    • people at risk of skin cancer (melanoma and non-melanoma type)
    • people with lighter skin types, such as skin types I or II on the Fitzpatrick scale12
    • people who are likely to require ciclosporin or long-term methotrexate
    • young people

  • offer lifetime skin cancer surveillance to people treated with PUVA who have:
    • had more than 150 PUVA treatments or
    • developed skin cancer

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.